Amount Raised
$10 Million
Round Type
Funding Round
OxnardDescription
CURE Pharmaceutical Holdings (OTC: CURR), a developer and manufacturer of innovative delivery formulations for drugs, supplements and wellness products, today announced that it has received the first tranche of $4 million of a committed financing of $10 million, after original issue discounts, through the issuance of convertible notes (the “Notes”). Axiom Capital Management, Inc. acted as the sole placement agent in the transaction.
Who to call at Cure Pharmaceutical Holding Corp., and when
A new round usually means Cure Pharmaceutical Holding Corp. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cure Pharmaceutical Holding Corp. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cure Pharmaceutical Holding Corp., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cure Pharmaceutical Holding Corp.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cure Pharmaceutical Holding Corp. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Cure Pharmaceutical Holding Corp. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.